SCHEMBL5050336

SCHEMBL5050336

Clc1ccc(-c2c(-c3ccccc3)nnn2Cc2ccc(Br)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 2/20 0.54
CDC7 O00311 2/20 0.51
MAP4K4 O95819 2/20 0.51
PIM1 P11309 2/20 0.51
PRKACA P17612 2/20 0.51
CDK2 P24941 2/20 0.51
GSK3B P49841 2/20 0.51
HIPK2 Q9H2X6 2/20 0.51
CLK4 Q9HAZ1 2/20 0.51
MKNK2 Q9HBH9 2/20 0.51
CYP19A1 P11511 3/20 0.49
PLK4 O00444 1/20 0.49
AURKA O14965 1/20 0.49
MAPK13 O15264 1/20 0.49
DAPK3 O43293 1/20 0.49
ROCK2 O75116 1/20 0.49
RPS6KA5 O75582 1/20 0.49
PRKD3 O94806 1/20 0.49
PRKCG P05129 1/20 0.49
CDK1 P06493 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5051921 1.00 TDO2 (0.54) TDO2CDC7MAP4K4PIM1PRKACA
SCHEMBL5049567 0.90 CDC7 (0.60) TDO2CDC7MAP4K4PIM1PRKACA
SCHEMBL5051897 0.90 CDC7 (0.60) TDO2CDC7MAP4K4PIM1PRKACA
SCHEMBL28000406 0.83 TDO2 (0.53) TDO2CDC7MAP4K4PIM1PRKACA
SCHEMBL2898117 0.83 IDO1 (0.65) TDO2CDC7MAP4K4PIM1PRKACA
SCHEMBL28326488 0.79 CYP19A1 (0.43) TDO2CDC7MAP4K4PIM1PRKACA
SCHEMBL5047930 0.77 MEN1 (0.52) CDK2AURKAMAPK1MEN1HTT
SCHEMBL5053635 0.74 SLC9A1 (0.49) CYP19A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL5047920 0.74 SLC9A1 (0.49) CYP19A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL28000407 0.73 TDO2 (0.51) TDO2CDC7MAP4K4PIM1PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed